Inhibiting inflammasome; the possible mechanisms of action of azithromycin against COVID-19?

2021 ◽  
Vol 6 (1) ◽  
pp. e10-e10
Author(s):  
Ali Saeedi-Boroujeni ◽  
Mohammad Bahadoram ◽  
Bijan Keikhaei ◽  
Mohammad-Reza Mahmoudian-Sani ◽  
Azadeh Khayyat ◽  
...  

Cytokine storm and destructive inflammation in the severe form of COVID-19 lead to acute respiratory distress syndrome (ARDS)/acute lung injury (ALI), and dysfunction of several different body organs in patients. SARS-CoV-2 contains all inflammasome-activating proteins belonging to SARS-CoV and MERS-CoV viruses. Macrolides are known to possess immunomodulatory properties. Given the desirable results of azithromycin treatment for patients with a severe case of COVID-19, based on studies, it could be concluded that the immunomodulatory properties of azithromycin to inhibit inflammasome can help the treatment of patients with this disease.

2010 ◽  
Vol 57 (4) ◽  
pp. 25-32
Author(s):  
Vesna Bumbasirevic ◽  
Bojan Jovanovic ◽  
Djordje Bajec ◽  
Zaneta Terziski ◽  
Milena Pandurovic ◽  
...  

Acute lung injury(ALI)and its more severe form acute respiratory distress syndrome (ARDS) are syndromes with a spectrum of increasing severity of lung injury defined by physiologic and radiographic criteria. There are many clinical disorders associated with the development of ALI/ARDS and can be divided into those associated with direct or indirect lung injury. Early detection and protective lung ventilation strategy contribute to lowering the mortality rate.


Sign in / Sign up

Export Citation Format

Share Document